It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1995.
1995 | Mumbai, Maharashtra, India | ActiveAksigen Pharmaceuticals Private Limited, a active private limited company, was established on 09 August 1995 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1995PTC091631. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹0.10 M.
Formerly known as Aksign Finvest Private Limited. It upholds a compliant status. Employing 2 professional, Its leadership includes Siddharth Bharat Daftary (Director), Gautam Vinod Daftary (Director). Past directors included Bharat Vinod Daftary, Siddharth Bharat Daftary. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 17Th Floor, Hoechst House Nariman Point, Mumbai, Mumbai, Maharashtra, 400021.
U24239MH1995PTC091631
091631
09 August 1995
₹2.00 Cr
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Aksigen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siddharth Bharat Daftary | Director | 07 Dec 2023 | Current |
| Gautam Vinod Daftary | Director | 09 Aug 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aksigen Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 33.33% decrease. The company also saw a substantial fall in profitability, with a 31.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 111%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Aksigen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Aksigen Pharmaceuticals has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aksigen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aksigen Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aksigen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Aksigen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Siddharth Bharat Daftary was appointed as a Director was appointed as a Director on 07 Dec 2023 & has been associated with this company since 1 year 11 months . was completed.
The activity Gautam Vinod Daftary was appointed as a Director was appointed as a Director on 09 Aug 2005 & has been associated with this company since 20 years 3 months . was completed.
The activity Aksigen Pharmaceuticals Private Limited was registered on 09 Aug 1995 with Roc Mumbai & aged 30 years 3 months as per MCA records. was completed.
The CIN of Aksigen Pharmaceuticals Private Limited is U24239MH1995PTC091631.
Aksigen Pharmaceuticals Private Limited is headquartered at 17Th Floor, Hoechst House Nariman Point, Mumbai, Mumbai, Maharashtra, 400021.
Aksigen Pharmaceuticals Private Limited was incorporated on 09 August 1995.
The current directors of Aksigen Pharmaceuticals Private Limited are
The primary industry of Aksigen Pharmaceuticals Private Limited is Manufacturing.
Aksigen Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aksigen Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹0.10 M.
The compliance status of Aksigen Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX